Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study
- Resource Type
- Article
- Source
- In
The Lancet Infectious Diseases December 2022 22(12):1681-1693 - Subject
Primary Research Articles - Language
- ISSN
- 1473-3099